PPBT · Purple Biotech Ltd ADR
United States · RS rating 11 · As of 2026-11-03
| Price | 1.17 USD |
|---|---|
| 1-day change | -4.9% |
| RS rating (overall / 1M / 3M / 12M) | 11 / 16 / 29 / 7 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 14 / 5 / 14 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -9900.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +86.6% |
| Market cap (USD) | $7.0M |